DO IS INVEST IN NEW ANTIBIOTICS IN WAYS THAT ACTUALLY ENCOURAGE APPROPRIATE USE AND SALES OF THOSE ANTIBIOTICS AND THAT REALLY IS THE CHALLENGE HERE